Vancomycin Hydrochloride
62 NDCs across 17 manufacturers|59 Generic,3 Brand
Vancomycin Hydrochloride is used to treat diarrhea, bacterial endocarditis, pseudomembranous enterocolitis, pneumococcal meningitis, neutropenia and postoperative complications, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 15, 1986, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient.
Vancomycin Hydrochloride is available as 62 NDCs from 17 manufacturers (59 generic, 3 brand), with NADAC prices from $1.33 to $39.32 per EA — the most expensive product costs about 30× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
62
59G / 3B
Manufacturers
17
competing in market
Price Spread
$1.33 – $39.32
per EA, 45 of 62 NDCs
7d Activity
avg -3.6% WoW · of 62 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
ANI Pharmaceuticals, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Glycopeptide Antibacterial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
17 manufacturers producing VANCOMYCIN HYDROCHLORIDE(1 pricing outlier)
Frequently Asked Questions
What is Vancomycin Hydrochloride used to treat?
Vancomycin Hydrochloride is used to treat diarrhea, bacterial endocarditis, pseudomembranous enterocolitis, pneumococcal meningitis, neutropenia and postoperative complications, per the National Library of Medicine's MED-RT classification.
When did Vancomycin Hydrochloride become available as a generic?
FDA approved the first generic Vancomycin Hydrochloride (ANDA) on Jan 1, 1982. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Vancomycin Hydrochloride products are on the market?
The Vancomycin Hydrochloride drug market contains 62 NDCs from 17 manufacturers — 59 generic and 3 brand products.
What is the price range for Vancomycin Hydrochloride?
NADAC reference prices for Vancomycin Hydrochloride range from $1.3290 to $39.3160 per EA — the most expensive product costs about 30× the cheapest. 17 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Vancomycin Hydrochloride?
17 manufacturers list Vancomycin Hydrochloride in NADAC. Ranked by number of NDCs, the largest are ANI Pharmaceuticals, Inc. (7), Hospira Inc. (6), Mylan Institutional LLC (4), Fresenius Kabi USA, LLC (4), Sagent Pharmaceuticals (4).
How has the price of Vancomycin Hydrochloride changed recently?
Over the past 7 days, 2 Vancomycin Hydrochloride NDCs rose and 12 fell, with a market-wide average change of -3.6%.